Eldon C. Mayer III - Mar 14, 2022 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
Ex VP & Chief Commerc. Officer
Signature
/s/ Sriram Ryali, Attorney-in-Fact
Stock symbol
EIGR
Transactions as of
Mar 14, 2022
Transactions value $
-$9,275
Form type
4
Date filed
3/14/2022, 09:21 PM
Previous filing
Mar 11, 2022
Next filing
Jan 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EIGR Common Stock Sale -$9.27K -1.66K -2.67% $5.60 60.5K Mar 14, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 14, 2022 for 3,959 shares.